The Novartis Group comprises three unique divisions:
1) Innovative Medicines
Our specialist business units, Novartis Oncology and Novartis Pharmaceuticals, form our Innovative Medicines Division. Our mission is to discover new ways to improve and extend people’s lives. We use science-based innovation to deliver better patient outcomes and help achieve our mission.
2) Generics and Biosimilars
Sandoz is the generic pharmaceutical division of Novartis and has a long history of providing high quality, affordable products to the NHS. The company is a global leader in generic medicines and biosimilars and strives to discover new ways to improve and extend lives. Please visit www.sandoz.uk.com for further information.
3) Eyecare Devices
Alcon is a leader in ophthalmology care in the UK and specialises in contact lens products and surgical devices. Alcon has one mission: to discover new ways to enhance sight and improve people's lives. Please visit www.uk.alcon.com for further information.
WHERE WE ARE IN THE UK
Novartis champions scientific research and innovation to help improve healthcare and reimagine medicine, both in the UK and around the world. Our work in the UK spans four locations; Frimley, Sittingbourne, Watchmoor Park and Grimsby – these sites are responsible for manufacturing and commercialising our products.
We are proud to be one of the only international pharmaceutical companies to have a local manufacturing facility in the UK (based in Grimsby). Over the last 10 years, we have invested £270m into our Grimsby site where we manufacture the active ingredients for many of our innovative medicines:
To find out more information about our manufacturing work in the UK, please click here
To find out more about what we do at each of our UK sites, please click here to enlarge the infographic below
Sittingbourne, our Near Patient Testing site, is at the heart of our commitment to healthcare innovation. Our team in Sittingbourne has recently developed a novel patient diagnostic testing kit which could mean that patients gain a more instant diagnosis with their GP, and avoid waiting times. To find out more, click here.
NOVARTIS AND EMPLOYMENT
We employ approximately 1,500 people in the UK and our work opportunities are gaining national recognition – we are proud to have been awarded the exclusive 'Top Employers certification' for exceptional employee offerings four years in a row (2014, 2015, 2016, 2017)
We value local expertise and talent; Novartis UK has an exciting, future talent programme with placements for undergraduates, graduates and apprenticeships.
COMMITMENT TO RESEARCH AND DEVELOPMENT
At Novartis we are committed to using science-based innovation to help address some of society’s most challenging healthcare issues.
We invest approximately £1 million a week into research and development (R&D) in the UK. This is greater than the average amount of revenue spent on R&D by the UK pharmaceutical industry.
We are proud to work in partnership with the NHS and patient advocacy groups to identify new ways to improve patient care in the UK. We believe in being transparent about our partnerships with different organisations; for further information on such collaborations, please see our Partnering with the NHS and Partnering with Patient Groups webpages.
SUPPORTING PATIENTS IN THE UK
Clinical trials are fundamental to the development of innovative medicines, help improve and extend patients’ lives and enable earlier access to latest medical research. We are passionate about contributing to life sciences in the UK and support over 10% of all clinical trials in this country – that’s more than any other company. For more information about our medical research please visit this page
Within our Innovative Medicines division, our work covers multiple disease areas including: cardiology, immunology and dermatology, neuroscience, ophthalmology, respiratory and oncology. For more information about how Novartis works within these disease areas, please visit this page.
NOVARTIS IN THE COMMUNITY
‘Community Partnership Day’
2017 marked our 21st Community Partnership Day, commemorating the 1996 creation of Novartis. This annual event provides all Novartis associates the opportunity to dedicate a work day to volunteer within local communities – colleagues took part across six continents and 84 countries.
Our associates have participated in a wide range of projects including: • Hosting a tea party for Surrey Heath Age Concern in the borough of Surrey Heath • Sorting and collecting donations for the Just 4 Kids charity shop • Supporting with garden renovations at Carwarden House Community School • Sorting registration and donations for the Dash of Colour event for the Phyllis Tuckwell Hospice • Running a food bank donation scheme